Find Support for Your Role
Life Sciences organizations rely on specialized teams to move products from development through approval and into market. Each function faces its own documentation pressures, regulatory expectations, and translation risks.
Solutions Designed for Every Role
Whatever your role, translation should never be the bottleneck. We make sure it isn’t.
Explore how Welo Life Sciences supports clinical, regulatory, safety, device, and commercial teams operating in highly regulated environments.
I Work in Clinical Operations
I Work in Regulatory Affairs
I Work in PV & Post Market Surveillance
I Work in IFU, Labeling & Artwork (Medical Devices & IVD)
I Work in Commercial & Marketing
Clinical Operations
We keep global studies moving across markets because clinical trials don’t wait.
Clinical Operations teams coordinate complex studies across investigators, regulators, sponsors, and CRO partners in multiple countries. Protocols evolve, amendments arrive, and patient-facing materials must remain accurate and synchronized across regions as trials progress.
Even small inconsistencies in multilingual documentation can delay ethics approvals, slow site activation, or introduce risk during regulatory review.
In global trials, translation may be just one step in the process. But when it breaks consistency, the impact is felt across the entire study.
Where Language Risk Appears
Language risk often surfaces during critical trial milestones:
- Ethics committee delays triggered by inconsistent informed consent translations
- Protocol amendment updates creating version conflicts
- Patient comprehension issues in localized study materials
- Terminology inconsistencies across protocol, site, and regulatory documentation
How We Support Clinical Operations
- Diverse services portfolio to support the entire trial lifecycle
- Clinical trial translation workflows built for global studies
- Rapid amendment management and version control
- Centralized terminology governance and AI-enabled consistency checks across document sets
- Audit-ready documentation aligned to regulatory expectations
- eTMF integration including Veeva Vault
- End-to-end (e)COA management, and COA Linguistic Validation
Regulatory Affairs
Submissions that hold up under authority scrutiny. We treat regulatory accuracy as seriously as regulators do.
Regulatory Affairs teams operate where scientific accuracy, submission timelines, and evolving global regulatory requirements meet. Documentation must remain consistent across markets while meeting the specific requirements of regulatory authorities worldwide.
As development programs expand across markets, maintaining alignment across translated submissions, labeling updates, and regulatory correspondence becomes increasingly complex.
The consequences of inconsistency are procedural, not just linguistic.
Where Language Risk Appears
Regulatory language issues can introduce scrutiny during submission and review:
- Documentation not fully aligned with competent authority templates
- Translation inaccuracies triggering clarification requests
- Inconsistent terminology across multilingual submission dossiers
- Labeling content inconsistent with approved submission dossiers
- Formatting or localization errors delaying regulatory review
How We Support Regulatory Affairs
- Regulatory translation support across the full submission lifecycle
- Regulatory document translation aligned to submission requirements
- Multilingual consistency across dossiers and regulatory correspondence
- Structured quality controls supporting inspection readiness
- AI-enabled workflows that maintain consistency across submissions
Pharmacovigilance & Post-Market Surveillance
Speed matters. Precision matters more. We deliver both.
Pharmacovigilance teams operate in highly time-sensitive environments where safety information moves quickly between affiliates, regulators, and global safety systems. Case narratives, product complaints, and safety documentation must be processed, reviewed, translated, and submitted within strict reporting timelines.
In this environment, translation is not simply a documentation task. It is part of the saftety workflow itself.
Where Language Risk Appears
- Delays translating safety narratives and case documentation under reporting timelines
- Misinterpretation of adverse event descriptions
- Terminology inconsistencies across safety reports
- Manual intake and file handling slowing down case processing
- Lack of standardized templates creating unnecessary rework across safety documentation
How Welo Life Sciences Supports Safety Teams
- AI-enabled workflow that reduces manual effort
- Scalable support for global safety operations
- Rapid 6-, 12-, and 24-hour global safety delivery solutions
- Multilingual support for safety documentation translation
- AI-assisted consistency checks across safety documentation
- Quality controls aligned to global safety requirements
IFU, Labeling and Artwork
Device documentation that holds across every market. One Device. Dozens of markets. Zero room for error.
Medical device and IVD teams manage highly regulated product documentation that must remain aligned across markets, packaging formats, and product updates. Labeling including, Instructions for Use, on-device identification, and packaging artwork, must meet regulatory frameworks while ensuring clear user comprehension.
Multilingual errors here create both compliance risk and operational disruption.
Where Language Risk Appears
- Inconsistent translations across labeling and documentation, including IFUs
- Artwork or packaging updates introducing version conflicts
- Regulatory non-compliance due to terminology or formatting inconsistencies
- Delays in global product registration due to documentation inconsistencies
How We Support Your Team
- Multilingual localization of IFUs, labeling, and device documentation
- Structured workflows supporting global regulatory compliance
- Terminology governance for device documentation
- Integrated artwork and packaging workflows
- AI-enabled consistency controls across device content sets
Commercial & Marketing
Global launch content that stays consistent and compliant. Creative enough for marketing. Precise enough for life sciences.
Commercial and Medical Affairs teams bring products to market while balancing brand strategy, scientific accuracy, and regulatory compliance. Launch materials, medical communications, and training content must remain aligned across markets and regional regulatory frameworks.
As global launches expand, maintaining consistent multilingual messaging becomes critical to both regulatory compliance and brand integrity.
Where Language Risk Appears
- Regulatory compliance risks in localized marketing content
- Inconsistent messaging across markets
- Misalignment between medical, regulatory, and commercial terminology
- Delays in global product launch readiness from content translation bottlenecks
- Digital and multimedia assets losing clarity or impact across markets
How We Support Marketing and Commercial Teams
- Multilingual support for global product launches
- Translation and transcreation for regulated marketing content
- Terminology governance across commercial and scientific contentÂ
- AI-enabled workflows supporting global campaign scale
- Creative production and localization support
- Multilingual training and e-learning courses creation and translation
Supporting Teams with Confidence
Every function across the product lifecycle depends on accurate, consistent multilingual documentation. Welo Life Sciences supports clinical, regulatory, safety, device, and commercial teams with workflows designed for regulated environments.